22nd Century EBITDA 2012-2026 | XXII

22nd Century ebitda from 2012 to 2026. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
22nd Century Annual EBITDA
(Millions of US $)
2025 $-10
2024 $-13
2023 $-40
2022 $-29
2021 $-27
2020 $-18
2019 $-22
2018 $-23
2017 $-12
2016 $-11
2015 $-11
2014 $-11
2013 $2
2012 $-2
2011 $-4
22nd Century Quarterly EBITDA
(Millions of US $)
2026-03-31 $-3
2025-12-31 $-3
2025-09-30 $-3
2025-06-30 $-3
2025-03-31 $-2
2024-12-31 $-4
2024-09-30 $-3
2024-06-30 $-2
2024-03-31 $-4
2023-12-31 $-14
2023-09-30 $-7
2023-06-30 $-11
2023-03-31 $-9
2022-12-31 $1
2022-09-30 $-14
2022-06-30 $-9
2022-03-31 $-8
2021-12-31 $-9
2021-09-30 $-7
2021-06-30 $-6
2021-03-31 $-5
2020-12-31 $-6
2020-09-30 $-4
2020-06-30 $-4
2020-03-31 $-4
2019-12-31 $-5
2019-09-30 $-7
2019-06-30 $-5
2019-03-31 $-5
2018-12-31 $-5
2018-09-30 $-6
2018-06-30 $-7
2018-03-31 $-5
2017-12-31 $-4
2017-09-30 $-3
2017-06-30 $-3
2017-03-31 $-3
2016-12-31 $-3
2016-09-30 $-2
2016-06-30 $-3
2016-03-31 $-3
2015-12-31 $-3
2015-09-30 $-3
2015-06-30 $-2
2015-03-31 $-4
2014-12-31 $-6
2014-09-30 $-3
2014-06-30 $-2
2014-03-31 $-1
2013-12-31 $6
2013-09-30 $-1
2013-06-30 $-2
2013-03-31 $-1
2012-12-31 $0
2012-09-30 $0
2012-06-30 $-1
2012-03-31 $0
2011-12-31 $-1
2011-09-30 $-1
2011-06-30 $-1
Sector Industry Market Cap Revenue
Consumer Staples Tobacco Products $0.001B $0.018B
22nd Century Group, Inc. is a plant biotechnology company focused on decreasing/increasing the level of nicotine in the tobacco plant through genetic engineering and breeding. The Company is focused on development of smoking cessation aid and owns and controls several patents. The company's products include X-22, a prescription smoking cessation aid, which is a tobacco-based botanical medical product for use as a smoking cessation therapy. 22nd Century Group, Inc. is based in Williamsville, New York.
Stock Name Country Market Cap PE Ratio
Philip Morris (PM) United States $250.066B 21.28
British American Tobacco (BTI) United Kingdom $120.087B 0.00
Altria (MO) United States $112.613B 12.43
JAPAN TOB (JAPAY) Japan $66.869B 20.69
Imperial Tobacco Group (IMBBY) United Kingdom $32.506B 0.00
Turning Point Brands (TPB) United States $1.616B 26.70
Universal (UVV) United States $1.332B 13.73
Ispire Technology (ISPR) United States $0.100B 0.00
Charlie's Holdings (CHUC) United States $0.066B 24.20